title: Percutaneous transvenous mitral commissurotomy.
abstract: Two hundred patients underwent Percutaneous transvenous mitral commissurotomy (PTMC) from January 2003 to July 2004. Seventy four percent of the patients were female. Age ranged from 10 years old to 61 years and mean age was 29 years. Twenty three percent of the patients were under 21 years of age. Atrial fibrillation was present in 32.0% of the cases. Mean mitral valve area increased from 0.90cm2 (+/- 0.14) to 1.82cm2 (+/- 0.21) (p = 0.018). Left atrial mean pressure decreased from 21 mmHg mean to 7 mmHg. Subjective improvement was reported in 98.0% of the patients immediately after the procedure. There was no mortality during the hospital stay or within the first month of the procedure. Significant mitral regurgitation of grade 3 was noted in 5 patients. Two developed severe mitral regurgitation. The complications were negligible. One had systemic embolisation during the procedure which recovered over a period of time. One developed deep vein thrombosis which recovered after treatment.
authors.affiliation: Department of Cardiology, Shahid Gangalal National Heart Center, Bansbari, Kathmandu. rajibrbhandari@yahoo.com
authors.forename: Rajib
authors.initials: R
authors.lastname: Rajbhandari
authors.forename: Man Bahadur
authors.initials: MB
authors.lastname: Kc
authors.forename: Yadav
authors.initials: Y
authors.lastname: Bhatta
authors.forename: Shyam
authors.initials: S
authors.lastname: Regmi
authors.forename: Rabi
authors.initials: R
authors.lastname: Malla
authors.forename: Sujeeb
authors.initials: S
authors.lastname: Rajbhandari
authors.forename: Deewakar
authors.initials: D
authors.lastname: Sharma
authors.forename: Ranjit
authors.initials: R
authors.lastname: Sharma
authors.forename: Subodh
authors.initials: S
authors.lastname: Kansakar
authors.forename: Sundeep
authors.initials: S
authors.lastname: Mishra
authors.forename: Bhagwan
authors.initials: B
authors.lastname: Koirala
mesh_terms: D000293:Adolescent; D000328:Adult; D002404:Catheterization / Q000009:adverse effects; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000209:etiology; D008946:Mitral Valve Stenosis / Q000628:therapy*; D011446:Prospective Studies; D012214:Rheumatic Heart Disease / Q000628:therapy*; D016896:Treatment Outcome